Cardiovasc

Cardiovasc has a technology for growing functional endothelial cells in places where they normally do not grow. The company's two-part platform is built on a surface activation process that covalently bonds agents to materials, and a synthetic peptide, P-15, that attracts and anchors endothelial cells. The company's initial product will be a catheter-delivered stent, coated with the peptide, designed to encourage complete endothelialization and renew the interiors of aged and failing saphenous vein coronary bypass grafts.